November 2019

Anti-inflammatory OTC Meds Double as Antidepressants
Customers looking to lift the winter blues or alleviate depression may need to look no further than common OTC medications or supplements. A new study indicates that a number of prescription and OTC anti-inflammatories effectively relieve depression on their own and boost the effects of standard antidepressant treatment. Read more.


Caution Patients About OTC Meds and Supplements With DOACs
Direct-acting oral anticoagulants (DOACs) have far fewer food and drug interactions than warfarin, but that doesn't mean that they don't have any, or that the ones they have are not serious. That message seems not to have been transmitted to many patients on the newer blood thinners. A recent study found that about one-third of DOAC patients take an OTC product with a potentially serious interaction daily. Read more.

Sanofi Recalls All Zantac
OTC Medications

Following FDA identification of N-nitrosodimethylamine contamination in Zantac and generic ranitidine, Sanofi has issued a voluntary recall of all its Zantac OTC medications in the United States. Read more and find out how pharmacists can help patients who take ranitidine to better understand their options. 

Hypoglycemia Patient
Teaching Aid

When blood sugar drops below 70 mg/dL, it is a signal that the body is becoming hypoglycemic. The most common symptoms include dizziness, fatigue, weakness, headaches, inability to concentrate, confusion, inappropriate behavior that can be mistaken for drunkenness, slurred speech, blurred vision, seizures, and coma. Read more and view a Patient Teaching Aid video.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App